Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T12:05:32.730Z.
Calculation as of: 2026-10-06T12:05:32.730Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: adca945f375d0863f0f013440b023eebfab0caffb47005764e85a23fe93f72ce
EARNINGS YIELD
N/A
EARNINGS YIELD AVG TTM
N/A
EARNINGS YIELD AVG 3Y
N/A
EARNINGS YIELD AVG 5Y
N/A
EARNINGS YIELD AVG 10Y
N/A
EARNINGS YIELD AVG 15Y
N/A
EARNINGS YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Aquestive Therapeutics, Inc.
Market Cap
$573.38M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$579.88M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$561.67M
Earnings Yield
N/A
TTM Avg
14.56%
3Y Avg
17.63%
5Y Avg
17.63%
Market Cap
$596.36M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$547.86M
Earnings Yield
0.08%
TTM Avg
0.28%
3Y Avg
0.28%
5Y Avg
0.28%
Market Cap
$519.25M
Earnings Yield
N/A
TTM Avg
516.44%
3Y Avg
516.44%
5Y Avg
516.44%
Market Cap
$517.73M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | $573.38M | N/A | N/A | N/A | N/A |
| CorMedix Inc. (CRMD)vs › | $569.56M | 29.34% | 23.65% | 17.74% | 17.74% |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $579.88M | N/A | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $561.67M | N/A | 14.56% | 17.63% | 17.63% |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $596.36M | N/A | N/A | N/A | N/A |
| Delcath Systems, Inc. (DCTH)vs › | $547.86M | 0.08% | 0.28% | 0.28% | 0.28% |
| Altimmune, Inc. (ALT)vs › | $519.25M | N/A | 516.44% | 516.44% | 516.44% |
| Crescent Biopharma, Inc. (CBIO)vs › | $517.79M | N/A | N/A | N/A | N/A |
| Allogene Therapeutics, Inc. (ALLO)vs › | $517.73M | N/A | N/A | N/A | N/A |
| Climb Bio, Inc. (CLYM)vs › | $632.76M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS YIELD |
|---|---|
| 2024-05-07 | 0.25% |
| 2024-05-06 | 0.24% |
| 2024-05-03 | 0.24% |
| 2024-05-02 | 0.26% |
| 2024-05-01 | 0.25% |
| 2024-04-30 | 0.25% |
| 2024-04-29 | 0.23% |
| 2024-04-26 | 0.21% |
| 2024-04-25 | 0.22% |
| 2024-04-24 | 0.22% |
| 2024-04-23 | 0.20% |
| 2024-04-22 | 0.19% |
| 2024-04-19 | 0.21% |
| 2024-04-18 | 0.19% |
| 2024-04-17 | 0.22% |
| 2024-04-16 | 0.22% |
| 2024-04-15 | 0.22% |
| 2024-04-12 | 0.22% |
| 2024-04-11 | 0.21% |
| 2024-04-10 | 0.21% |
| 2024-04-09 | 0.21% |
| 2024-04-08 | 0.21% |
| 2024-04-05 | 0.21% |
| 2024-04-04 | 0.20% |
| 2024-04-03 | 0.19% |
| 2024-04-02 | 0.21% |
| 2024-04-01 | 0.21% |
| 2024-03-28 | 0.20% |
| 2024-03-27 | 0.21% |
| 2024-03-26 | 0.21% |
| 2024-03-25 | 0.20% |
| 2024-03-22 | 0.19% |
| 2024-03-21 | 0.19% |
| 2024-03-20 | 0.19% |
| 2024-03-19 | 0.16% |
| 2024-03-18 | 0.15% |
| 2024-03-15 | 0.14% |
| 2024-03-14 | 0.16% |
| 2024-03-13 | 0.16% |
| 2024-03-12 | 0.17% |
| 2024-03-11 | 0.17% |
| 2024-03-08 | 0.17% |
| 2024-03-07 | 0.15% |
| 2024-03-06 | 0.17% |
